TACI (Human):Fc (Human), Recombinant, aa2-118 (TNFRSF 13B, Tumor Necrosis Factor Receptor Superfamily Member 13B, Transmembrane Activator and CAML interactor, CD267)
Catalog No : USB-045324
525.30€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | TACI (Human):Fc (Human), Recombinant, aa2-118 (TNFRSF 13B, Tumor Necrosis Factor Receptor Superfamily Member 13B, Transmembrane Activator and CAML interactor, CD267) | ||
|---|---|---|---|
| Catalog No | USB-045324 | ||
| Supplier’s Catalog No | 045324 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, Human, HEK 293 cells | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 45 | ||
| Storage | 4°C/-20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | ≥90% (SDS-PAGE). Endotoxin: <0.01EU/ug (LAL test; Lonza) | ||
| Form | Supplied as a lyophilized powder in PBS. Reconstitute with 50ul sterile ddH2O. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | ≥90% (SDS-PAGE). Endotoxin: <0.01EU/ug (LAL test; Lonza) | ||
| Description | B-cell activating factor belonging to the TNF family receptor (BAFF-R), B-cell maturation antigen (BCMA), and transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) play critical functions in promoting B-cell survival by engaging the ligands a proliferation-inducing ligand (APRIL) and/or BAFF. TACI is predominantly expressed on peripheral blood B cells and interacts with the B cell activating factor (BAFF) of ligands and a proliferation inducing ligand (APRIL), which are expressed by numerous cell types, including dendritic cells, macrophages and neutrophils. TNFRSF13B, the gene, which encodes TACI is mutated in nearly 10% of patients with common variable immune deficiency (CVID), an antibody deficiency syndrome characterized by loss of memory B cells and plasma cells. Sequence: The extracellular domain of human TACI (aa2-118) is fused at the C-terminus to the Fc portion of human IgG1. Biological Activity: Inhibits BAFF and APRIL activity. Molecular Weight: ~45kD (SDS-PAGE) Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months after receipt at -20°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved